Sanara MedTech (SMTI) Competitors $34.04 +0.53 (+1.58%) Closing price 04:00 PM EasternExtended Trading$34.09 +0.05 (+0.15%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMTI vs. BLFS, ESTA, MDXG, PLSE, INMD, IRMD, TNDM, EMBC, BBNX, and KMTSShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include BioLife Solutions (BLFS), Establishment Labs (ESTA), MiMedx Group (MDXG), Pulse Biosciences (PLSE), InMode (INMD), iRadimed (IRMD), Tandem Diabetes Care (TNDM), Embecta (EMBC), Beta Bionics (BBNX), and Kestra Medical Technologies (KMTS). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Its Competitors BioLife Solutions Establishment Labs MiMedx Group Pulse Biosciences InMode iRadimed Tandem Diabetes Care Embecta Beta Bionics Kestra Medical Technologies Sanara MedTech (NASDAQ:SMTI) and BioLife Solutions (NASDAQ:BLFS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings. Is SMTI or BLFS more profitable? BioLife Solutions has a net margin of -5.39% compared to Sanara MedTech's net margin of -10.22%. BioLife Solutions' return on equity of 0.16% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.22% -26.43% -10.69% BioLife Solutions -5.39%0.16%0.14% Do analysts rate SMTI or BLFS? Sanara MedTech currently has a consensus price target of $50.00, indicating a potential upside of 46.89%. BioLife Solutions has a consensus price target of $31.29, indicating a potential upside of 20.93%. Given Sanara MedTech's higher possible upside, research analysts plainly believe Sanara MedTech is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Do institutionals & insiders have more ownership in SMTI or BLFS? 8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are held by institutional investors. 42.6% of Sanara MedTech shares are held by company insiders. Comparatively, 2.2% of BioLife Solutions shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings and valuation, SMTI or BLFS? Sanara MedTech has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Sanara MedTech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M3.50-$9.66M-$1.16-29.34BioLife Solutions$82.25M15.07-$20.18M-$0.12-215.58 Does the media refer more to SMTI or BLFS? In the previous week, Sanara MedTech had 2 more articles in the media than BioLife Solutions. MarketBeat recorded 6 mentions for Sanara MedTech and 4 mentions for BioLife Solutions. Sanara MedTech's average media sentiment score of 0.55 beat BioLife Solutions' score of 0.18 indicating that Sanara MedTech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sanara MedTech 1 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioLife Solutions 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, SMTI or BLFS? Sanara MedTech has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.78, indicating that its stock price is 78% more volatile than the S&P 500. SummaryBioLife Solutions beats Sanara MedTech on 10 of the 17 factors compared between the two stocks. Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$298.32M$10.94B$5.75B$9.85BDividend YieldN/A1.85%6.67%4.51%P/E Ratio-29.3421.6878.4326.42Price / Sales3.5031.25546.94119.09Price / CashN/A24.5637.0558.92Price / Book7.653.5710.916.06Net Income-$9.66M$212.34M$3.29B$266.28M7 Day Performance0.92%-3.31%0.01%-0.76%1 Month Performance37.48%7.76%7.06%3.83%1 Year Performance-1.59%-8.09%50.09%24.39% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech2.0855 of 5 stars$34.04+1.6%$50.00+46.9%-2.8%$298.32M$86.67M-29.3460News CoverageBLFSBioLife Solutions1.6142 of 5 stars$24.49-2.3%$31.29+27.8%+2.5%$1.18B$82.25M-205.23440ESTAEstablishment Labs2.2562 of 5 stars$40.72-1.3%$56.50+38.8%-9.1%$1.18B$166.02M-13.351,018News CoveragePositive NewsMDXGMiMedx Group3.4492 of 5 stars$7.17+1.0%$12.00+67.4%+11.3%$1.06B$348.88M34.17870News CoveragePositive NewsPLSEPulse Biosciences4.1186 of 5 stars$15.64+0.7%$22.00+40.6%-12.3%$1.05B$700K-14.90140News CoveragePositive NewsINMDInMode3.7705 of 5 stars$14.60-2.3%$18.04+23.6%-7.7%$924.19M$394.82M5.92480Positive NewsIRMDiRadimed4.8267 of 5 stars$72.13-0.4%$72.00-0.2%+54.1%$920.10M$73.24M44.65110Positive NewsTNDMTandem Diabetes Care4.6679 of 5 stars$12.89+3.0%$22.47+74.3%-70.4%$868.34M$940.20M-4.162,650Positive NewsShort Interest ↓EMBCEmbecta4.5784 of 5 stars$14.42-0.4%$19.00+31.8%-13.1%$841.61M$1.12B10.062,100Positive NewsBBNXBeta BionicsN/A$18.78-0.3%$22.56+20.1%N/A$816.37M$65.12M0.00294News CoveragePositive NewsKMTSKestra Medical Technologies1.5507 of 5 stars$15.55-3.7%$27.33+75.8%N/A$798.49M$59.81M0.00300Positive NewsLockup Expiration Related Companies and Tools Related Companies BioLife Solutions Competitors Establishment Labs Competitors MiMedx Group Competitors Pulse Biosciences Competitors InMode Competitors iRadimed Competitors Tandem Diabetes Care Competitors Embecta Competitors Beta Bionics Competitors Kestra Medical Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMTI) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
